Insiders Egetis Therapeutics AB

Equities

EGTX

SE0003815604

Real-time Estimate Cboe Europe Other stock markets 03:36:14 16/05/2024 pm IST			5-day change	1st Jan Change
6.855 ^SEK	+2.01%		+7.66%	+20.97%

03/05	Egetis Therapeutics AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
22/02	Egetis Therapeutics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Egetis Therapeutics AB Appoints Laetitia Szaller as General Counsel and Head of Compliance	22/12	CI
Egetis Therapeutics AB Appoints Katayoun Welin-Berger as Vice President Operations, Effective from March 2023	27/23/27	CI
Egetis Therapeutics AB Announces Executive Changes	20/22/20	CI
Egetis presents Nomination Committee for the 2023 Annual General Meeting	25/22/25	AQ
Egetis Therapeutics AB Appoints Sara Melton as President of North America	20/22/20	CI
Egetis Therapeutics AB Announces Executive Changes	05/22/05	CI
Egetis Therapeutics AB Secures Conditional Acceptance for Emcitate® as Brand Name in the US	26/22/26	CI
Egetis Therapeutics Appoints Karl Hård as Head of Investor Relations and Communication, Effective February 1, 2022	25/22/25	CI
Nomination Committee appointed for the 2022 Annual General Meeting in Egetis Therapeutics	05/21/05	AQ
Egetis Therapeutics AB Announces Board Changes	05/21/05	CI
Egetis Therapeutics appoints Yilmaz Mahshid as new CFO	19/21/19	CI
Egetis Therapeutics AB Appoints Dr. Kristina Sjöblom Nygren as New Cmo, Effective May 1, 2021	15/21/15	CI
Egetis Therapeutics : Peder Walberg appointed as interim Chief Medical Officer	20/21/20	AQ
Egetis Therapeutics Announces Executive Changes	20/21/20	CI
Egetis Therapeutics : Nomination Committee appointed for the 2021 Annual General Meeting in Egetis Therapeutics	22/20/22	AQ
PledPharma AB will Change its Name to Egetis Therapeutics AB	18/20/18	CI
PledPharma AB Appoints Henrik Krook Takes as Vice President Commercial Operations	06/20/06	CI
PledPharma AB Elects Peder Walberg as New Board Member	28/20/28	CI
PledPharma AB Announces Changes in Board of Directors and Committees	30/20/30	CI
PledPharma AB Appoints Marie-Louise Alamaa as Interim CFO	24/20/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Egetis Therapeutics AB

Equities

EGTX

SE0003815604

Insiders

Filters